OPC Pharmaceutical JSC (HOSE:OPC)

Market Cap	1.53T +6.2%
Revenue (ttm)	1.13T +17.8%
Net Income	95.36B +12.5%
EPS	1,488.88 +6.7%
Shares Out	64.05M
PE Ratio	16.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,010
Open	23,900
Previous Close	23,900
Day's Range	23,900 - 23,900
52-Week Range	21,100 - 25,400
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 28, 2026

About OPC Pharmaceutical JSC

OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, hormones, external use, digestion, pain relief, anti-inflammatory, health gifts, and other drugs. It also offers nutritional products for health care, supplementing nutrients, nourishing the body, and boosting immunity. In additi...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 871
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: OPC

Financial Performance

In 2025, OPC Pharmaceutical JSC's revenue was 1.12 trillion, an increase of 15.94% compared to the previous year's 968.58 billion. Earnings were 98.50 billion, an increase of 4.33%.